tiprankstipranks
Entero Therapeutics (ENTO)
NASDAQ:ENTO
US Market

Entero Therapeutics (ENTO) Income Statement

1,209 Followers

Entero Therapeutics Income Statement

Last quarter (Q ), Entero Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Entero Therapeutics's net income was $-3.48M. See Entero Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ -595.00K---$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ -595.00K-----
Operating Expense
$ 9.40M$ 15.77M$ -12.68M$ -59.06M$ 26.43M$ 14.74M
Operating Income
$ -13.96M$ -15.77M$ -12.73M$ -56.70M$ -26.43M$ -14.74M
Net Non Operating Interest Income Expense
$ -1.73M$ -19.93K$ -1.72M$ -10.06K$ -5.84M$ -433.94K
Other Income Expense
$ -1.71M$ 4.22K$ -1.48M$ -529.10K$ -398.57K-
Pretax Income
$ -13.97M$ -15.79M$ -12.97M$ -58.59M$ -32.67M$ -15.18M
Tax Provision
----$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -13.56M$ -16.10M$ -13.26M$ -84.57M$ -41.73M$ -15.18M
Basic EPS
$ -35.64$ -47.88$ -21.00$ -9.47$ -11.50$ -6.80
Diluted EPS
$ -35.60$ -47.88$ -21.00$ -9.47$ -11.50$ -6.80
Basic Average Shares
$ 5.65M$ 336.34K$ 718.25K$ 8.93M$ 2.84M$ 2.24M
Diluted Average Shares
$ 5.65M$ 336.34K$ 718.25K$ 8.93M$ 2.84M$ 2.24M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 9.40M$ 15.77M$ -12.68M$ -59.06M$ 26.43M$ 14.74M
Net Income From Continuing And Discontinued Operation
$ -14.02M$ -15.79M$ -12.97M$ -58.54M$ -32.67M$ -15.18M
Normalized Income
$ -6.02M$ -12.48M--$ -32.06M$ -15.18M
Interest Expense
----$ 5.84M$ 433.94K
EBIT
$ -12.24M$ -15.77M$ -12.95M$ -58.57M$ -26.83M$ -14.74M
EBITDA
$ -12.21M$ -15.74M$ -12.92M$ -58.03M$ -26.27M$ -13.72M
Currency in USD

Entero Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis